The 2022 Medical Technology World Summit, held on December 14-15 at the Suzhou Lion Hill International Conference Center, was jointly organized by VB100, Vcbeat, Shell Research Institute, and the Suzhou High-tech Zone Management Committee. The summit focused on the convergence of technology and healthcare, bringing together industry, academia, research, and investment to promote innovation and development in the medical technology sector. A highlight of the summit was the VB-Find Award presentation.
Hillgene Biopharma was invited to attend the VB-Find Award ceremony, where its Cell and Gene Therapy CDMO comprehensive solution was recognized as the "Top 100 Innovative Medical Technology Products of 2022" in the category of Best Biotechnology Product (Solution).
This award, presented by Vcbeat's VB100 and Shell Research Institute, was open to healthcare companies across various domains and growth stages. It evaluated the most innovative medical technology products (solutions) within three major technology clusters: biotechnology, smart manufacturing and new materials technology, and digital and information technology. The judging panel consisted of industry association experts, seasoned investors, Shell Research Institute researchers, and healthcare industry media personnel, employing the AFIC-12Ps assessment model to weigh and score the annual performance of medical technology products/solutions across four dimensions: application value, driving support, innovation iteration, and interactive communication.
This recognition reaffirms Hillgene Biopharma's innovative "quality-centered" CQDMO service system and validates its outstanding service capabilities. As a participant in the track of industrializing cell therapy drugs, Hillgene Biopharma is dedicated to improving the efficiency of cell therapy drug industrialization from the source. They have independently developed a series of cell therapy-related technology platform systems with the goal of becoming a core player in China's future cell therapy drug treatment CDMO, providing high-quality comprehensive solutions for the industrialization of cell therapy drugs to their customers.
Post time: 2022-12-19 00:00:00
